Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous ...

Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western Technology played a key role in supporting ...

Both will build solar cells. Both will employ hundreds of people. But Two South Carolina communities took significantly ...

With a new leadership team and fast-track designation from the US Food and Drug Administration (FDA), clinical-stage oncology ...

While radiation treatments designed to kill cancer cells have come a long way, scientists and doctors are always exploring ...

Between the 2019-2020 to 2024-2025 fiscal years, the cost of upgrades to the regional sewage treatment plant, including ...

Capricor Therapeutics is expected to release data from the phase 3 HOPE-3 trial in Q3'25, thus presenting a potential path ...

Chronic kidney disease (CKD) is a silent epidemic. In this high-stakes space, biotechnology companies focused on reversing or ...

A lack of enough hospital beds during times of high demand has caused “significant backups in the Emergency Department.” ...

Report highlights deteriorating conditions at D.C. jail, overcrowding, and failing infrastructure. Calls for a new facility ...

Farmers who were worried their land would be expropriated to expand the Casselman Water Treatment Plant are relieved now the ...

Dr. Cohen is the Founder of Faces+, an advanced aesthetic and reconstructive surgery center in San Diego, California. With ...